Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan Dose-Finding Study in Essential Hypertension
NCT00937651Phase 2Completed
- Sponsor
- Boryung
- Start
- Apr 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of fimasartan in essential hypertension (4 arms), sponsored by Boryung. Primary endpoint: Reduction in Sitting Diastolic Blood Pressure at Day 27. Started Apr 2005; status: completed.
02
Drugs
fimasartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00937651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937651.